Proactiveinvestors Australia Paradigm Biopharmaceuticals Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Paradigm Biopharmaceuticals Ltd RSS feed en Tue, 20 Aug 2019 20:33:09 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Paradigm Biopharmaceuticals files Investigational New Drug submission for ZilosulÒ with FDA ]]> https://www.proactiveinvestors.com.au/companies/news/900252/paradigm-biopharmaceuticals-files-investigational-new-drug-submission-for-zilosul-with-fda-900252.html Wed, 07 Aug 2019 11:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900252/paradigm-biopharmaceuticals-files-investigational-new-drug-submission-for-zilosul-with-fda-900252.html <![CDATA[News - Paradigm Biopharmaceuticals director acquires 140,000 shares valued at almost $170,000 ]]> https://www.proactiveinvestors.com.au/companies/news/223250/paradigm-biopharmaceuticals-director-acquires-140000-shares-valued-at-almost-170000-223250.html Wed, 03 Jul 2019 16:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223250/paradigm-biopharmaceuticals-director-acquires-140000-shares-valued-at-almost-170000-223250.html <![CDATA[News - Paradigm Biopharmaceuticals CEO shows faith in company with $49,000 on-market purchase ]]> https://www.proactiveinvestors.com.au/companies/news/223170/paradigm-biopharmaceuticals-ceo-shows-faith-in-company-with-49000-on-market-purchase-223170.html Tue, 02 Jul 2019 16:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223170/paradigm-biopharmaceuticals-ceo-shows-faith-in-company-with-49000-on-market-purchase-223170.html <![CDATA[News - Paradigm Biopharmaceuticals Ltd fully funded as it advances iPPS development ]]> https://www.proactiveinvestors.com.au/companies/news/223006/paradigm-biopharmaceuticals-ltd-fully-funded-as-it-advances-ipps-development-223006.html Fri, 28 Jun 2019 15:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223006/paradigm-biopharmaceuticals-ltd-fully-funded-as-it-advances-ipps-development-223006.html <![CDATA[News - Paradigm Biopharmaceuticals receives positive results for Ross River clinical trial ]]> https://www.proactiveinvestors.com.au/companies/news/221424/paradigm-biopharmaceuticals-receives-positive-results-for-ross-river-clinical-trial-221424.html Tue, 04 Jun 2019 09:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221424/paradigm-biopharmaceuticals-receives-positive-results-for-ross-river-clinical-trial-221424.html <![CDATA[News - Paradigm Biopharmaceuticals receives more positive real-world patient data ]]> https://www.proactiveinvestors.com.au/companies/news/220992/paradigm-biopharmaceuticals-receives-more-positive-real-world-patient-data-220992.html Tue, 28 May 2019 09:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220992/paradigm-biopharmaceuticals-receives-more-positive-real-world-patient-data-220992.html <![CDATA[News - S&P/ASX 200 set for positive start as US markets have Monday holiday ]]> https://www.proactiveinvestors.com.au/companies/news/220990/spasx-200-set-for-positive-start-as-us-markets-have-monday-holiday-220990.html Tue, 28 May 2019 08:41:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220990/spasx-200-set-for-positive-start-as-us-markets-have-monday-holiday-220990.html <![CDATA[News - Paradigm Biopharmaceuticals completes retail component of $26.3 million entitlement offer ]]> https://www.proactiveinvestors.com.au/companies/news/219926/paradigm-biopharmaceuticals-completes-retail-component-of-263-million-entitlement-offer-219926.html Thu, 09 May 2019 11:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219926/paradigm-biopharmaceuticals-completes-retail-component-of-263-million-entitlement-offer-219926.html <![CDATA[News - Paradigm Biopharmaceuticals completes institutional component of $26.3 million entitlement offer ]]> https://www.proactiveinvestors.com.au/companies/news/218998/paradigm-biopharmaceuticals-completes-institutional-component-of-263-million-entitlement-offer-218998.html Wed, 24 Apr 2019 14:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218998/paradigm-biopharmaceuticals-completes-institutional-component-of-263-million-entitlement-offer-218998.html <![CDATA[News - Paradigm Biopharmaceuticals director buys shares on-market ]]> https://www.proactiveinvestors.com.au/companies/news/218985/paradigm-biopharmaceuticals-director-buys-shares-on-market-218985.html Wed, 24 Apr 2019 08:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218985/paradigm-biopharmaceuticals-director-buys-shares-on-market-218985.html <![CDATA[News - Paradigm Biopharmaceuticals secures $61.3 million in first stage of raising ]]> https://www.proactiveinvestors.com.au/companies/news/218723/paradigm-biopharmaceuticals-secures-613-million-in-first-stage-of-raising-218723.html Wed, 17 Apr 2019 10:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218723/paradigm-biopharmaceuticals-secures-613-million-in-first-stage-of-raising-218723.html <![CDATA[News - Paradigm Biopharmaceuticals phase 2b trial achieves key endpoints in OA of the knee ]]> https://www.proactiveinvestors.com.au/companies/news/218542/paradigm-biopharmaceuticals-phase-2b-trial-achieves-key-endpoints-in-oa-of-the-knee-218542.html Mon, 15 Apr 2019 14:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218542/paradigm-biopharmaceuticals-phase-2b-trial-achieves-key-endpoints-in-oa-of-the-knee-218542.html <![CDATA[News - Paradigm Biopharmaceuticals raising $77.9 million to fund its pivotal phase 3 OA trial ]]> https://www.proactiveinvestors.com.au/companies/news/218535/paradigm-biopharmaceuticals-raising-779-million-to-fund-its-pivotal-phase-3-oa-trial-218535.html Mon, 15 Apr 2019 12:27:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218535/paradigm-biopharmaceuticals-raising-779-million-to-fund-its-pivotal-phase-3-oa-trial-218535.html <![CDATA[News - Paradigm Biopharmaceuticals gets a speeding ticket for 18% price increase ]]> https://www.proactiveinvestors.com.au/companies/news/217370/paradigm-biopharmaceuticals-gets-a-speeding-ticket-for-18-price-increase-217370.html Thu, 28 Mar 2019 10:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217370/paradigm-biopharmaceuticals-gets-a-speeding-ticket-for-18-price-increase-217370.html <![CDATA[News - Paradigm Biopharmaceuticals director shows confidence with on-market share purchase ]]> https://www.proactiveinvestors.com.au/companies/news/216057/paradigm-biopharmaceuticals-director-shows-confidence-with-on-market-share-purchase-216057.html Fri, 08 Mar 2019 15:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216057/paradigm-biopharmaceuticals-director-shows-confidence-with-on-market-share-purchase-216057.html <![CDATA[News - Carnarvon Petroleum into S&P/ASX 300 – AC8, BGL, PAR into All Ordinaries ]]> https://www.proactiveinvestors.com.au/companies/news/216047/carnarvon-petroleum-into-spasx-300--ac8-bgl-par-into-all-ordinaries-216047.html Fri, 08 Mar 2019 09:22:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216047/carnarvon-petroleum-into-spasx-300--ac8-bgl-par-into-all-ordinaries-216047.html <![CDATA[News - Paradigm Biopharmaceuticals moving towards phase 2/3 MPS clinical trial ]]> https://www.proactiveinvestors.com.au/companies/news/214598/paradigm-biopharmaceuticals-moving-towards-phase-23-mps-clinical-trial-214598.html Thu, 14 Feb 2019 12:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/214598/paradigm-biopharmaceuticals-moving-towards-phase-23-mps-clinical-trial-214598.html <![CDATA[News - Paradigm Biopharmaceuticals to court partners and licensees for OA drug commercialisation ]]> https://www.proactiveinvestors.com.au/companies/news/213114/paradigm-biopharmaceuticals-to-court-partners-and-licensees-for-oa-drug-commercialisation-213114.html Tue, 22 Jan 2019 21:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213114/paradigm-biopharmaceuticals-to-court-partners-and-licensees-for-oa-drug-commercialisation-213114.html <![CDATA[News - Paradigm Biopharmaceutical shares surge on clinical trial success ]]> https://www.proactiveinvestors.com.au/companies/news/211356/paradigm-biopharmaceutical-shares-surge-on-clinical-trial-success-211356.html Tue, 18 Dec 2018 10:22:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211356/paradigm-biopharmaceutical-shares-surge-on-clinical-trial-success-211356.html <![CDATA[News - Paradigm Biopharmaceuticals to talk clinical trial results on conference call tomorrow morning ]]> https://www.proactiveinvestors.com.au/companies/news/211284/paradigm-biopharmaceuticals-to-talk-clinical-trial-results-on-conference-call-tomorrow-morning-211284.html Mon, 17 Dec 2018 15:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211284/paradigm-biopharmaceuticals-to-talk-clinical-trial-results-on-conference-call-tomorrow-morning-211284.html <![CDATA[News - Paradigm Biopharmaceuticals has results pending for phase 2b clinical trial ]]> https://www.proactiveinvestors.com.au/companies/news/211191/paradigm-biopharmaceuticals-has-results-pending-for-phase-2b-clinical-trial-211191.html Fri, 14 Dec 2018 11:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211191/paradigm-biopharmaceuticals-has-results-pending-for-phase-2b-clinical-trial-211191.html <![CDATA[News - Paradigm Biopharmaceuticals chief executive Paul Rennie buys more shares ]]> https://www.proactiveinvestors.com.au/companies/news/211113/paradigm-biopharmaceuticals-chief-executive-paul-rennie-buys-more-shares-211113.html Thu, 13 Dec 2018 16:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211113/paradigm-biopharmaceuticals-chief-executive-paul-rennie-buys-more-shares-211113.html <![CDATA[News - Paradigm Biopharmaceuticals gets more real world evidence of treatment success ]]> https://www.proactiveinvestors.com.au/companies/news/210726/paradigm-biopharmaceuticals-gets-more-real-world-evidence-of-treatment-success-210726.html Fri, 07 Dec 2018 10:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210726/paradigm-biopharmaceuticals-gets-more-real-world-evidence-of-treatment-success-210726.html <![CDATA[News - Paradigm Biopharmaceuticals gains on market with upcoming clinical trial read-out, wider treatment potential ]]> https://www.proactiveinvestors.com.au/companies/news/210374/paradigm-biopharmaceuticals-gains-on-market-with-upcoming-clinical-trial-read-out-wider-treatment-potential-210374.html Mon, 03 Dec 2018 03:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210374/paradigm-biopharmaceuticals-gains-on-market-with-upcoming-clinical-trial-read-out-wider-treatment-potential-210374.html <![CDATA[News - Paradigm Biopharmaceuticals ‘next Australian blockbuster biotech’, according to Fiftyone Capital ]]> https://www.proactiveinvestors.com.au/companies/news/210347/paradigm-biopharmaceuticals-next-australian-blockbuster-biotech-according-to-fiftyone-capital-210347.html Sun, 02 Dec 2018 21:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210347/paradigm-biopharmaceuticals-next-australian-blockbuster-biotech-according-to-fiftyone-capital-210347.html <![CDATA[News - Paradigm Biopharmaceuticals’ positive trial results potentially transformational, says Morgans research ]]> https://www.proactiveinvestors.com.au/companies/news/210271/paradigm-biopharmaceuticals-positive-trial-results-potentially-transformational-says-morgans-research-210271.html Fri, 30 Nov 2018 00:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210271/paradigm-biopharmaceuticals-positive-trial-results-potentially-transformational-says-morgans-research-210271.html <![CDATA[News - Paradigm Biopharmaceuticals signs agreement for use of iPPS in treatment of MPS ]]> https://www.proactiveinvestors.com.au/companies/news/209715/paradigm-biopharmaceuticals-signs-agreement-for-use-of-ipps-in-treatment-of-mps-209715.html Thu, 22 Nov 2018 11:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209715/paradigm-biopharmaceuticals-signs-agreement-for-use-of-ipps-in-treatment-of-mps-209715.html <![CDATA[News - Paradigm Biopharmaceuticals boosts financial position with $2.32 million R&D tax rebate ]]> https://www.proactiveinvestors.com.au/companies/news/209235/paradigm-biopharmaceuticals-boosts-financial-position-with-232-million-rd-tax-rebate-209235.html Thu, 15 Nov 2018 11:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/209235/paradigm-biopharmaceuticals-boosts-financial-position-with-232-million-rd-tax-rebate-209235.html <![CDATA[News - Paradigm Biopharmaceuticals secures $9 million to accelerate phase III ]]> https://www.proactiveinvestors.com.au/companies/news/207792/paradigm-biopharmaceuticals-secures-9-million-to-accelerate-phase-iii-207792.html Thu, 25 Oct 2018 10:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207792/paradigm-biopharmaceuticals-secures-9-million-to-accelerate-phase-iii-207792.html <![CDATA[News - Paradigm Biopharmaceuticals enters agreement to treat US-based sportspeople ]]> https://www.proactiveinvestors.com.au/companies/news/207807/paradigm-biopharmaceuticals-enters-agreement-to-treat-us-based-sportspeople-207807.html Thu, 25 Oct 2018 01:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207807/paradigm-biopharmaceuticals-enters-agreement-to-treat-us-based-sportspeople-207807.html <![CDATA[News - Paradigm Biopharmaceuticals enters trading halt ahead of capital raising ]]> https://www.proactiveinvestors.com.au/companies/news/207615/paradigm-biopharmaceuticals-enters-trading-halt-ahead-of-capital-raising-207615.html Tue, 23 Oct 2018 11:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207615/paradigm-biopharmaceuticals-enters-trading-halt-ahead-of-capital-raising-207615.html <![CDATA[News - Paradigm Biopharmaceuticals finalises Ross River virus trial recruitment ]]> https://www.proactiveinvestors.com.au/companies/news/203653/paradigm-biopharmaceuticals-finalises-ross-river-virus-trial-recruitment-203653.html Tue, 28 Aug 2018 13:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/203653/paradigm-biopharmaceuticals-finalises-ross-river-virus-trial-recruitment-203653.html <![CDATA[News - Paradigm Biopharmaceuticals new data shows 60% pain reduction, shares rise ]]> https://www.proactiveinvestors.com.au/companies/news/202902/paradigm-biopharmaceuticals-new-data-shows-60-pain-reduction-shares-rise-202902.html Wed, 15 Aug 2018 10:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202902/paradigm-biopharmaceuticals-new-data-shows-60-pain-reduction-shares-rise-202902.html <![CDATA[News - Paradigm Biopharmaceuticals completes recruitment for knee pain trial ]]> https://www.proactiveinvestors.com.au/companies/news/202244/paradigm-biopharmaceuticals-completes-recruitment-for-knee-pain-trial-202244.html Mon, 06 Aug 2018 10:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/202244/paradigm-biopharmaceuticals-completes-recruitment-for-knee-pain-trial-202244.html <![CDATA[News - Paradigm Biopharmaceuticals’ leaping share price attracts ASX speeding ticket ]]> https://www.proactiveinvestors.com.au/companies/news/200320/paradigm-biopharmaceuticals-leaping-share-price-attracts-asx-speeding-ticket-200320.html Mon, 09 Jul 2018 12:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200320/paradigm-biopharmaceuticals-leaping-share-price-attracts-asx-speeding-ticket-200320.html <![CDATA[News - Paradigm Biopharmaceuticals patients report over 50% pain reduction ]]> https://www.proactiveinvestors.com.au/companies/news/198908/paradigm-biopharmaceuticals-patients-report-over-50-pain-reduction-198908.html Fri, 15 Jun 2018 10:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198908/paradigm-biopharmaceuticals-patients-report-over-50-pain-reduction-198908.html <![CDATA[News - Paradigm Biopharmaceuticals osteoarthritis clinical trial ahead of schedule ]]> https://www.proactiveinvestors.com.au/companies/news/197147/paradigm-biopharmaceuticals-osteoarthritis-clinical-trial-ahead-of-schedule-197147.html Thu, 17 May 2018 10:52:00 +1000 https://www.proactiveinvestors.com.au/companies/news/197147/paradigm-biopharmaceuticals-osteoarthritis-clinical-trial-ahead-of-schedule-197147.html <![CDATA[News - Paradigm Biopharmaceuticals banking on near-term revenues from repurposing FDA approved drugs ]]> https://www.proactiveinvestors.com.au/companies/news/196873/paradigm-biopharmaceuticals-banking-on-near-term-revenues-from-repurposing-fda-approved-drugs-196873.html Mon, 14 May 2018 14:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196873/paradigm-biopharmaceuticals-banking-on-near-term-revenues-from-repurposing-fda-approved-drugs-196873.html <![CDATA[News - XTEK appoints experienced investment executive to its board ]]> https://www.proactiveinvestors.com.au/companies/news/195623/xtek-appoints-experienced-investment-executive-to-its-board-195623.html Tue, 24 Apr 2018 16:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195623/xtek-appoints-experienced-investment-executive-to-its-board-195623.html <![CDATA[News - Paradigm Biopharmaceuticals achieves pain treatment win with AFL players ]]> https://www.proactiveinvestors.com.au/companies/news/194287/paradigm-biopharmaceuticals-achieves-pain-treatment-win-with-afl-players-194287.html Thu, 05 Apr 2018 11:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194287/paradigm-biopharmaceuticals-achieves-pain-treatment-win-with-afl-players-194287.html <![CDATA[News - Paradigm Biopharmaceuticals’ osteoarthritis trial remains ahead of schedule ]]> https://www.proactiveinvestors.com.au/companies/news/193829/paradigm-biopharmaceuticals-osteoarthritis-trial-remains-ahead-of-schedule-193829.html Tue, 27 Mar 2018 11:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193829/paradigm-biopharmaceuticals-osteoarthritis-trial-remains-ahead-of-schedule-193829.html <![CDATA[News - Paradigm Biopharmaceuticals has success with PPS osteoarthritis treatment ]]> https://www.proactiveinvestors.com.au/companies/news/192384/paradigm-biopharmaceuticals-has-success-with-pps-osteoarthritis-treatment-192384.html Thu, 01 Mar 2018 09:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/192384/paradigm-biopharmaceuticals-has-success-with-pps-osteoarthritis-treatment-192384.html <![CDATA[News - Paradigm Biopharmaceuticals adds AFL legend to list of osteoarthritis treatment wins ]]> https://www.proactiveinvestors.com.au/companies/news/190792/paradigm-biopharmaceuticals-adds-afl-legend-to-list-of-osteoarthritis-treatment-wins-190792.html Tue, 30 Jan 2018 12:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190792/paradigm-biopharmaceuticals-adds-afl-legend-to-list-of-osteoarthritis-treatment-wins-190792.html <![CDATA[News - Paradigm Biopharmaceuticals eyes opportunities to treat osteoarthritis ]]> https://www.proactiveinvestors.com.au/companies/news/190512/paradigm-biopharmaceuticals-eyes-opportunities-to-treat-osteoarthritis-190512.html Wed, 24 Jan 2018 15:49:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190512/paradigm-biopharmaceuticals-eyes-opportunities-to-treat-osteoarthritis-190512.html <![CDATA[News - Paradigm Biopharmaceuticals granted European patent ]]> https://www.proactiveinvestors.com.au/companies/news/190053/paradigm-biopharmaceuticals-granted-european-patent-190053.html Tue, 16 Jan 2018 10:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190053/paradigm-biopharmaceuticals-granted-european-patent-190053.html <![CDATA[News - Paradigm Biopharmaceuticals ahead of schedule with trials ]]> https://www.proactiveinvestors.com.au/companies/news/187680/paradigm-biopharmaceuticals-ahead-of-schedule-with-trials-187680.html Thu, 23 Nov 2017 09:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187680/paradigm-biopharmaceuticals-ahead-of-schedule-with-trials-187680.html <![CDATA[News - Paradigm Biopharmaceuticals meets primary endpoint in clinical trial ]]> https://www.proactiveinvestors.com.au/companies/news/187194/paradigm-biopharmaceuticals-meets-primary-endpoint-in-clinical-trial-187194.html Tue, 14 Nov 2017 16:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187194/paradigm-biopharmaceuticals-meets-primary-endpoint-in-clinical-trial-187194.html <![CDATA[News - Paradigm Biopharmaceuticals funded into 2019 through placement ]]> https://www.proactiveinvestors.com.au/companies/news/186770/paradigm-biopharmaceuticals-funded-into-2019-through-placement-186770.html Mon, 06 Nov 2017 15:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186770/paradigm-biopharmaceuticals-funded-into-2019-through-placement-186770.html <![CDATA[News - Paradigm Biopharmaceuticals to finalise raising ]]> https://www.proactiveinvestors.com.au/companies/news/186609/paradigm-biopharmaceuticals-to-finalise-raising-186609.html Thu, 02 Nov 2017 09:26:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186609/paradigm-biopharmaceuticals-to-finalise-raising-186609.html <![CDATA[News - Paradigm has successfully dosed first participant in clinical trial for osteoarthritis ]]> https://www.proactiveinvestors.com.au/companies/news/186392/paradigm-has-successfully-dosed-first-participant-in-clinical-trial-for-osteoarthritis-186392.html Mon, 30 Oct 2017 15:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186392/paradigm-has-successfully-dosed-first-participant-in-clinical-trial-for-osteoarthritis-186392.html